Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
NCT ID: NCT05829512
Eligibility Criteria: Inclusion Criteria: * Menstrual pain that begins within a few months or within 2 years of menarche * Pain that starts just before or at the beginning of menstruation, * Pain in the lower abdomen and back, which may radiate to the inner thighs or both * Pain, episodic and cramping pain, rarely lasting more than 72 hours, * Pain similar to one menstrual cycle and additional symptoms such as nausea and vomiting, fatigue, headache, dizziness and sleep disturbances, * Do not have any diagnosed chronic disease or a past or present psychological disorder, * Able to speak, read and write Turkish. Exclusion Criteria: * Those with psychiatric and cognitive effects such as psychosis, bipolar disorder, eating disorder, moderate or severe depression or somatic symptom disorder, * Those who participate in psychotherapy because of dysmenorrhea symptoms (currently or in the past), women in pregnancy and lactation, * Having acute suicidal tendencies, gynecological diseases (hysterectomy, oophorectomy, gynecological cancer, polycystic ovary syndrome, endometriosis, infertility), * Those who have used antidepressants, benzodiazepines/antipsychotics, oral contraceptives or hormones (e.g. thyroid hormones) in the last 3 months or have had a change in their use, * With any neurological disorder, * Can't speak, read or write Turkish.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT05829512
Study Brief:
Protocol Section: NCT05829512